Patents by Inventor Leslie Demars

Leslie Demars has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11965189
    Abstract: The present invention relates to cellobiohydrolase variants having increased thermal activity or thermostability, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 24, 2017
    Date of Patent: April 23, 2024
    Assignee: Novozymes A/S
    Inventors: Mark Wogulis, Leslie DeMars, David Osborn
  • Publication number: 20220307002
    Abstract: The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: April 6, 2022
    Publication date: September 29, 2022
    Applicant: Novozymes, Inc.
    Inventors: Janine Lin, Doreen Bohan, Michelle Maranta, Leslie DeMars, Michael Lamsa, Matt Sweeny, Mark David Wogulis, Elizabeth Znameroski, Frank Winther Rasmussen
  • Patent number: 11053489
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: July 6, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Publication number: 20200325463
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 15, 2020
    Applicant: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Publication number: 20200299664
    Abstract: The present invention relates to cellobiohydrolase variants having increased thermal activity or thermostability, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 24, 2017
    Publication date: September 24, 2020
    Applicant: Novozymes A/S
    Inventors: Mark Wogulis, Leslie DeMars, David Osborn
  • Patent number: 10738293
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Grant
    Filed: March 2, 2017
    Date of Patent: August 11, 2020
    Assignee: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn
  • Publication number: 20190085309
    Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.
    Type: Application
    Filed: March 2, 2017
    Publication date: March 21, 2019
    Applicant: Novozymes A/S
    Inventors: Mark Wogulis, Leslie Demars, Aubrey Jones, Hanshu Ding, David Osborn